DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+7.51%
US · US
DLTR.US latest organized financial period shows revenue grew +10.43% YoY and net income grew +142% YoY. Current price is about 95.77 USD, while the model base case is about 86.32 USD; the current price sits +10.9% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:27
Hover each model row to inspect formulas and inputs.
+10.95%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+7.51%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+10.95%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -1.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
+26.11%
Updated: 2026/04/29 15:27
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2024/02/03 | Asset impairment | Impairment | -11M USD | Medium |
| 2023/01/28 | Asset impairment | Impairment | -11M USD | Medium |
| 2025/11/01 | Asset impairment | Impairment | -553K USD | Medium |
| 2025/08/02 | Asset impairment | Impairment | -79K USD | Medium |
| 2025/05/03 | Asset impairment | Impairment | -79K USD | Medium |
| 2024/11/02 | Asset impairment | Impairment | -2M USD | Medium |
| 2024/08/03 | Asset impairment | Impairment | -316K USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2026/01/31 | Annual | 19B USD | 1B USD | - | - | 6.22 | - |
| 2025/02/01 | Annual | 18B USD | -3B USD | - | 2B USD | -14.03 | - |
| 2024/02/03 | Annual | 31B USD | -998M USD | -987M USD | 3B USD | -4.55 | -4.5 |
| 2023/01/28 | Annual | 28B USD | 2B USD | 2B USD | 2B USD | 7.21 | 7.26 |
| 2022/01/29 | Annual | 26B USD | 1B USD | - | 1B USD | 5.8 | - |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.